Bids are being invited by the Accelerated Access Collaborative (AAC) from specialist independent teams to evaluate the winning technologies from round 1 of the AI in Health and Care Award.
The AI in Health and Care Award forms part of the NHS AI Lab and is managed by the AAC – whose membership includes the AHSN Network – in partnership with NHSX and the National Institute for Health Research (NIHR).
The evaluations will assess whether these technologies should be recommended for wider adoption across the NHS and will look at their safety, effectiveness, and impact. Evaluations will be conducted with a real-world perspective and follow NICE appraisal processes.
This call for evaluation teams is split into two stages:
Stage 1: a shortlisting competition where Bidders can indicate which of the technology winners from round one they are bidding to evaluate. Bidders should apply using the Bravo platform using the relevant link below.
- Route A: for bidders who have no prior relationship working with the technologies they wish to express an interest in. Submission is via Bravo portal, using the code ITT_869, by 9 October 2020 at 12pm.
- Route B (fast track): for bidders who have a prior relationship, in an evaluator capacity, working with the technologies they wish to express an interest in. Submission is via Bravo portal, using the code Itt_782 by 5 October 2020 at 10:00am.
Stage 2: following a shortlisting process successful bidders will be invited to a further competition where they will develop an evaluation scoping plan for the technology/ies they have expressed an interest in from 16 October 2020 with a deadline expected to be 6 November 2020.
The Bravo portal also provides further information for bidders.
Everyone who registers their interest early via the Bravo portal will be invited to join a webinar on September 30 from 13:30 – 14:30 where they will have the opportunity to ask any questions about the AI in Health and Care Awards and the bidding process. Questions and answers will be shared on the Bravo portal for those that cannot attend the webinar.